Asaumi, R., Toshimoto, K., Tobe, Y., Hashizume, K., Nunoya, K., Imawaka, H., . . . Sugiyama, Y. (2018). Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug‐Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects. CPT Pharmacometrics Syst Pharmacol.
استشهاد بنمط شيكاغوAsaumi, Ryuta, Kota Toshimoto, Yoshifusa Tobe, Kenta Hashizume, Ken‐ichi Nunoya, Haruo Imawaka, Wooin Lee, و Yuichi Sugiyama. "Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug‐Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects." CPT Pharmacometrics Syst Pharmacol 2018.
MLA استشهادAsaumi, Ryuta, et al. "Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug‐Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects." CPT Pharmacometrics Syst Pharmacol 2018.